Impact of Dietary Fats on Cognitive Function
Official title: Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study: Dietary Fat Quality and Cognitive Impairment
Run by Ohio State University · NCT06223672 · Data updated 2026-11-12
This study tests whether eating walnuts or a dairy-free chocolate bar can improve thinking and memory in adults who feel their brain isn't working as well as it used to.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 88 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | February 7, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | April 21, 2026 |
| Trial ID | NCT06223672 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with subjective cognitive impairment and a BMI of 30 or greater.
✕Probably not a fit
Patients with diagnosed cognitive impairment, dementia, or significant dietary restrictions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research investigates how dietary fats, specifically walnuts and a dairy-free chocolate bar, affect cognitive function after meals in adults experiencing subjective cognitive complaints. Participants will consume one of the study snacks daily for a week, and the study will measure changes in cognitive performance and the gut-brain axis. The trial employs a randomized crossover design to ensure robust comparisons between the effects of the different dietary fats.
Why it matters
Potential benefit: If successful, this study could lead to dietary recommendations that enhance cognitive function in individuals with cognitive complaints.
How similar studies have gone: Other studies have explored the relationship between diet and cognitive function, suggesting potential benefits, but this specific approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjective cognitive impairment * BMI ≥30 kg/m2 * HbA1C \<6.5% Exclusion Criteria: * Diagnosis og cognitive impairment or dementia * Montreal Cognitive Assessment (MoCA) score of \<26 * Current or previous diagnosis of Diabetes or use of diabetes medications * Current diagnosis of or current treatment of cancer other than non-melanoma skin cancer * Gastrointestinal diseases or disorders (including pancreatic and gastric bypass surgery) where consumption of the study foods would be contraindication or where the disease or disorder could negatively affect nutrient absorption and/or would prevent participants from tolerating the study foods * Hyperthyroidism diagnosis * Food Allergy or intolerances * Any dietary restriction where consumption of the study foods, study meals/snack or meal challenge or any ingredient would be contraindicated * Use of some oil supplements in the past 4 weeks prior to enrolling * Pregnancy and lactation * Inability to access veins for venipuncture * Antibiotic use in the past month * Psychostimulant or nootropic medication use * Current use of supplements or medications for weight loss or following a weight loss program * Severe or uncontrolled autoimmune diseases * Current or previous diagnosis of severe kidney failure, liver cirrhosis and some pulmonary diseases * Heart disease events (including stroke or heart attack) within last 3 months prior to enrollment * Alcohol or drug abuse
Where it's running
-
The Ohio State University
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Martha Belury, PhD, RDN — Ohio State University
- Study coordinator: Martha Belury, PhD, RDN
- Email: belury.1@osu.edu
- Phone: 614-292-1680
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Accelerated rTMS for Cognitive Function in adults with mild to moderate cognitive impairment
This study tests whether a short course of accelerated rTMS with the EXOMIND device can improve thinking skills in adults ages 50–90 with mild cognitive impairment or mild dementia.
-
Cognitive screening and multidomain care to slow memory and thinking decline in older adults with type 2 diabetes
This study will test whether regular cognitive screening plus a two-year program of medication optimization, adjusted HbA1c targets, vascular risk management, lifestyle changes, and social support can slow cognitive decline in people aged 65 and older with type 2 diabetes.
-
Making cognitive screening easy for primary care providers
This project will test an automated Spanish‑language risk assessment and brief iPad cognitive screen to help primary care teams find early memory and thinking problems in people aged 60 and older.
-
Memantine plus structured exercise to protect thinking and memory during breast cancer chemotherapy
This will test whether memantine combined with a supervised exercise program, memantine alone, or a placebo can prevent or reduce thinking and memory problems in people receiving chemotherapy for stage I–III breast cancer.
-
Effects of different anesthesia techniques on cognitive function in elderly hip fracture patients
This study tests different anesthesia methods to see which one helps older patients with hip fractures keep their thinking skills sharp during and after surgery.
-
Combining sleep promotion and cognitive training to improve brain function in older ICU survivors
This study is testing if helping older adults who survived ICU treatment sleep better and do brain exercises can improve their thinking skills.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.